US Stock MarketDetailed Quotes

Bone Biologics (BBLG)

Watchlist
  • 1.390
  • +0.070+5.30%
Close Apr 17 15:10 ET
  • 1.390
  • 0.0000.00%
Post 20:01 ET
2.50MMarket Cap-0.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bone Biologics (BBLG) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
0
Operating expense
-23.33%3.23M
-52.85%733.11K
-24.79%715.27K
-7.61%748.08K
14.94%1.04M
-55.25%4.22M
34.05%1.55M
-54.30%951.02K
-73.37%809.67K
-71.29%903.54K
Selling and administrative expenses
4.12%2.17M
5.67%475.91K
1.19%527.47K
21.18%556.47K
-6.54%614.91K
-17.13%2.09M
-36.83%450.37K
3.01%521.27K
-38.33%459.22K
18.14%657.91K
-General and administrative expense
4.12%2.17M
5.67%475.91K
1.19%527.47K
21.18%556.47K
-6.54%614.91K
-17.13%2.09M
-36.83%450.37K
3.01%521.27K
-38.33%459.22K
18.14%657.91K
Research and development costs
-50.23%1.06M
-76.72%257.2K
-56.30%187.81K
-45.32%191.61K
72.45%423.58K
-69.16%2.13M
147.07%1.1M
-72.71%429.75K
-84.73%350.44K
-90.52%245.63K
Operating profit
23.33%-3.23M
52.85%-733.11K
24.79%-715.27K
7.61%-748.08K
-14.94%-1.04M
55.25%-4.22M
-34.05%-1.55M
54.30%-951.02K
73.37%-809.67K
71.29%-903.54K
Net non-operating interest income expense
119.16%121.98K
136.70%47.96K
136.71%47.33K
-56.07%6.65K
7,758.43%20.04K
2,879.66%55.66K
5,706.30%20.26K
3,630.04%19.99K
3,439.02%15.15K
-54.14%255
Non-operating interest income
119.16%121.98K
136.70%47.96K
136.71%47.33K
-56.07%6.65K
7,758.43%20.04K
2,879.66%55.66K
5,706.30%20.26K
3,630.04%19.99K
3,439.02%15.15K
-54.14%255
Other net income (expense)
-92.23%3.97K
-96.16%498
112.15%1.21K
-91.64%902
-96.37%1.36K
-89.31%51.08K
103.32%12.96K
-106.21%-9.97K
-99.15%10.79K
106.63%37.31K
Gain on sale of security
-92.23%3.97K
-96.16%498
112.15%1.21K
-91.64%902
-96.37%1.36K
-94.28%51.08K
-47.67%12.96K
-106.21%-9.97K
-99.15%10.79K
106.63%37.31K
Special income (charges)
----
----
----
----
----
--0
----
----
----
----
Income before tax
24.40%-3.11M
55.01%-684.64K
29.15%-666.74K
5.51%-740.52K
-17.45%-1.02M
54.04%-4.11M
1.82%-1.52M
50.98%-941K
55.70%-783.73K
76.66%-865.97K
Income tax
Net income
24.40%-3.11M
55.01%-684.64K
29.15%-666.74K
5.51%-740.52K
-17.45%-1.02M
54.04%-4.11M
1.82%-1.52M
50.98%-941K
55.70%-783.73K
76.66%-865.97K
Net income continuous Operations
24.40%-3.11M
55.01%-684.64K
29.15%-666.74K
5.51%-740.52K
-17.45%-1.02M
54.04%-4.11M
1.82%-1.52M
50.98%-941K
55.70%-783.73K
76.66%-865.97K
Minority interest income
Net income attributable to the parent company
24.40%-3.11M
55.01%-684.64K
29.15%-666.74K
5.51%-740.52K
-17.45%-1.02M
54.04%-4.11M
1.82%-1.52M
50.98%-941K
55.70%-783.73K
76.66%-865.97K
Preferred stock dividends
Other preferred stock dividends
0
0
0
3.21M
0
3.21M
Net income attributable to common stockholders
57.56%-3.11M
55.01%-684.64K
83.95%-666.74K
5.51%-740.52K
-17.45%-1.02M
18.15%-7.32M
1.82%-1.52M
-116.36%-4.15M
55.70%-783.73K
76.66%-865.97K
Basic earnings per share
90.85%-2.65
87.66%-0.3814
97.40%-0.37
66.92%-1.33
75.57%-1.92
85.81%-28.96
82.24%-3.0908
51.67%-14.21
87.14%-4.02
97.63%-7.86
Diluted earnings per share
90.85%-2.65
87.66%-0.3814
97.40%-0.37
66.92%-1.33
75.57%-1.92
85.81%-28.96
82.24%-3.0908
51.67%-14.21
87.14%-4.02
97.63%-7.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit 0
Operating expense -23.33%3.23M-52.85%733.11K-24.79%715.27K-7.61%748.08K14.94%1.04M-55.25%4.22M34.05%1.55M-54.30%951.02K-73.37%809.67K-71.29%903.54K
Selling and administrative expenses 4.12%2.17M5.67%475.91K1.19%527.47K21.18%556.47K-6.54%614.91K-17.13%2.09M-36.83%450.37K3.01%521.27K-38.33%459.22K18.14%657.91K
-General and administrative expense 4.12%2.17M5.67%475.91K1.19%527.47K21.18%556.47K-6.54%614.91K-17.13%2.09M-36.83%450.37K3.01%521.27K-38.33%459.22K18.14%657.91K
Research and development costs -50.23%1.06M-76.72%257.2K-56.30%187.81K-45.32%191.61K72.45%423.58K-69.16%2.13M147.07%1.1M-72.71%429.75K-84.73%350.44K-90.52%245.63K
Operating profit 23.33%-3.23M52.85%-733.11K24.79%-715.27K7.61%-748.08K-14.94%-1.04M55.25%-4.22M-34.05%-1.55M54.30%-951.02K73.37%-809.67K71.29%-903.54K
Net non-operating interest income expense 119.16%121.98K136.70%47.96K136.71%47.33K-56.07%6.65K7,758.43%20.04K2,879.66%55.66K5,706.30%20.26K3,630.04%19.99K3,439.02%15.15K-54.14%255
Non-operating interest income 119.16%121.98K136.70%47.96K136.71%47.33K-56.07%6.65K7,758.43%20.04K2,879.66%55.66K5,706.30%20.26K3,630.04%19.99K3,439.02%15.15K-54.14%255
Other net income (expense) -92.23%3.97K-96.16%498112.15%1.21K-91.64%902-96.37%1.36K-89.31%51.08K103.32%12.96K-106.21%-9.97K-99.15%10.79K106.63%37.31K
Gain on sale of security -92.23%3.97K-96.16%498112.15%1.21K-91.64%902-96.37%1.36K-94.28%51.08K-47.67%12.96K-106.21%-9.97K-99.15%10.79K106.63%37.31K
Special income (charges) ----------------------0----------------
Income before tax 24.40%-3.11M55.01%-684.64K29.15%-666.74K5.51%-740.52K-17.45%-1.02M54.04%-4.11M1.82%-1.52M50.98%-941K55.70%-783.73K76.66%-865.97K
Income tax
Net income 24.40%-3.11M55.01%-684.64K29.15%-666.74K5.51%-740.52K-17.45%-1.02M54.04%-4.11M1.82%-1.52M50.98%-941K55.70%-783.73K76.66%-865.97K
Net income continuous Operations 24.40%-3.11M55.01%-684.64K29.15%-666.74K5.51%-740.52K-17.45%-1.02M54.04%-4.11M1.82%-1.52M50.98%-941K55.70%-783.73K76.66%-865.97K
Minority interest income
Net income attributable to the parent company 24.40%-3.11M55.01%-684.64K29.15%-666.74K5.51%-740.52K-17.45%-1.02M54.04%-4.11M1.82%-1.52M50.98%-941K55.70%-783.73K76.66%-865.97K
Preferred stock dividends
Other preferred stock dividends 0003.21M03.21M
Net income attributable to common stockholders 57.56%-3.11M55.01%-684.64K83.95%-666.74K5.51%-740.52K-17.45%-1.02M18.15%-7.32M1.82%-1.52M-116.36%-4.15M55.70%-783.73K76.66%-865.97K
Basic earnings per share 90.85%-2.6587.66%-0.381497.40%-0.3766.92%-1.3375.57%-1.9285.81%-28.9682.24%-3.090851.67%-14.2187.14%-4.0297.63%-7.86
Diluted earnings per share 90.85%-2.6587.66%-0.381497.40%-0.3766.92%-1.3375.57%-1.9285.81%-28.9682.24%-3.090851.67%-14.2187.14%-4.0297.63%-7.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -